Research overview
What is Sermorelin?
Sermorelin is a synthetic fragment corresponding to the first 29 amino acids of GHRH. It signals the pituitary to release growth hormone when that pathway responds. It differs from long-acting CJC-1295 with DAC and ghrelin-receptor agonists like Ipamorelin.
What has research examined?
An original study of continuous GHRH(1–29) infusion measured GH secretion and growth in a clinical context. An evidence review describes diagnostic responses and limited pediatric deficiency data, while noting uncertainty about final height and comparative effectiveness. None establishes benefit for healthy adults or unsupervised product use.
Endocrine challenge results do not diagnose an individual or validate a supplier vial. The calculator is user-entered mass-volume arithmetic only, not a hormone-treatment instruction.
Research references
- Continuous GHRH(1–29) infusion, GH secretion, and growthClinical endocrinology study
- Sermorelin in diagnosis and pediatric GH deficiency: evidence reviewPaediatric Drugs; clinical review
Calculation boundary
The calculator performs concentration arithmetic only when a user enters a mass and liquid volume. It does not verify identity, formulation, purity, sterility, stability, compatibility, biological-unit equivalence, or whether reconstitution applies to a particular product. Do not convert IU or other biological units to mg without an authoritative, exact-product relationship.